• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

pH响应性脂质体——聚乙二醇化对胶质母细胞瘤细胞释放动力学和细胞摄取的影响

The pH-Responsive Liposomes-The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells.

作者信息

Rustad Eirik A L, von Hofsten Susannah, Kumar Robin, Lænsman Eirik A, Berge Gerd, Škalko-Basnet Nataša

机构信息

Drug Transport and Delivery Research Group, Department of Pharmacy, UiT The Arctic University of Norway, 9019 Tromsø, Norway.

Tumor Biology Research Group, Department of Medical Biology, UiT The Arctic University of Norway, 9019 Tromsø, Norway.

出版信息

Pharmaceutics. 2022 May 25;14(6):1125. doi: 10.3390/pharmaceutics14061125.

DOI:10.3390/pharmaceutics14061125
PMID:35745698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9227832/
Abstract

Nanomedicine has been, to a certain degree, a success story in the development of superior anticancer therapies. However, there are tumors that remain a huge challenge for nanoformulations, for instance, brain tumors such as glioblastoma, the most common and aggressive brain tumor. To utilize the fact that such tumors are characterized by an acidic extracellular environment, we selected pH-responsive liposomes as a potential drug delivery system for superior delivery to GBM. Liposomes comprising PEGylated lipid of two chain lengths with encapsulated fluorescent marker calcein were characterized and challenged against non-PEGylated vesicles. The in vitro calcein release from three liposomal formulations (<200 nm), namely non-PEGylated (pH-Lip) and PEGylated, pH-Lip−PEG750, and pH-Lip−PEG2000, was followed at three pH conditions to prove the pH-responsiveness. The intracellular delivery of a liposomally encapsulated marker was determined in GL261 glioblastoma cell lines in vitro using both flow cytometry and confocal microscopy. The inclusion of PEG2000 within liposomal formulation resulted in reduced in vitro pH-responsiveness compared to pH-Lip and pH-Lip750. All three pH-responsive liposomal formulations improved intracellular uptake in GL261 cells compared to non-pH-responsive liposomes, with negligible differences regarding PEG length. The proposed formulations should be further evaluated in glioblastoma models.

摘要

在开发卓越的抗癌疗法方面,纳米医学在一定程度上取得了成功。然而,仍有一些肿瘤对纳米制剂构成巨大挑战,例如脑肿瘤,如胶质母细胞瘤,这是最常见且侵袭性最强的脑肿瘤。为利用此类肿瘤细胞外环境呈酸性这一特点,我们选择了pH响应型脂质体作为一种潜在的药物递送系统,以实现对胶质母细胞瘤的高效递送。对包含两种链长的聚乙二醇化脂质且包裹有荧光标记物钙黄绿素的脂质体进行了表征,并与未聚乙二醇化的囊泡进行了对比。在三种pH条件下监测了三种脂质体制剂(<200 nm),即未聚乙二醇化的(pH-Lip)、聚乙二醇化的pH-Lip−PEG750和pH-Lip−PEG2000中钙黄绿素的体外释放情况,以证明其pH响应性。使用流式细胞术和共聚焦显微镜在体外GL261胶质母细胞瘤细胞系中测定了脂质体包裹标记物的细胞内递送情况。与pH-Lip和pH-Lip750相比,脂质体制剂中加入PEG2000导致体外pH响应性降低。与非pH响应性脂质体相比,所有三种pH响应型脂质体制剂均提高了GL261细胞的细胞内摄取,聚乙二醇长度方面的差异可忽略不计。所提出的制剂应在胶质母细胞瘤模型中进一步评估。

相似文献

1
The pH-Responsive Liposomes-The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells.pH响应性脂质体——聚乙二醇化对胶质母细胞瘤细胞释放动力学和细胞摄取的影响
Pharmaceutics. 2022 May 25;14(6):1125. doi: 10.3390/pharmaceutics14061125.
2
PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study.聚乙二醇化与非聚乙二醇化pH敏感脂质体:一项对比抗肿瘤活性研究的新见解
Pharmaceutics. 2022 Jan 24;14(2):272. doi: 10.3390/pharmaceutics14020272.
3
pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin.pH-温度双重敏感载药脂质体锚定聚乙二醇化金纳米粒子用于触发阿霉素的递送
Int J Pharm. 2022 May 10;619:121691. doi: 10.1016/j.ijpharm.2022.121691. Epub 2022 Mar 21.
4
Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.聚(2-乙基-2-恶唑啉)-胆固醇半琥珀酸酯构建的pH敏感脂质体用于阿霉素递送的设计与评价
Eur J Pharm Biopharm. 2015 Apr;91:66-74. doi: 10.1016/j.ejpb.2015.01.030. Epub 2015 Feb 7.
5
Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.脂质体包裹的卡铂通过对流增强递送增加了携带 F98 神经胶质瘤大鼠的中位生存时间。
J Nanobiotechnology. 2018 Oct 5;16(1):77. doi: 10.1186/s12951-018-0404-8.
6
Convection-enhanced delivery of liposomal drugs for effective treatment of glioblastoma multiforme.对流增强脂质体药物递送用于多形性胶质母细胞瘤的有效治疗。
Drug Deliv Transl Res. 2020 Dec;10(6):1876-1887. doi: 10.1007/s13346-020-00773-w.
7
A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.一种 pH 响应性 α-螺旋细胞穿透肽介导的脂质体递药系统。
Biomaterials. 2013 Oct;34(32):7980-93. doi: 10.1016/j.biomaterials.2013.07.014. Epub 2013 Jul 24.
8
The involvement of extracellular vesicles in the transcytosis of nanoliposomes through brain endothelial cells, and the impact of liposomal pH-sensitivity.细胞外囊泡在纳米脂质体通过脑内皮细胞的转胞吞作用中的参与,以及脂质体pH敏感性的影响。
Mater Today Bio. 2022 Feb 5;13:100212. doi: 10.1016/j.mtbio.2022.100212. eCollection 2022 Jan.
9
Uptake and intracellular release kinetics of liposome formulations in glioma cells.脂质体制剂在神经胶质瘤细胞中的摄取和细胞内释放动力学。
Int J Pharm. 2010 Aug 16;395(1-2):251-9. doi: 10.1016/j.ijpharm.2010.05.017. Epub 2010 Jun 1.
10
Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.聚(乙二醇)-嵌段-聚(ε-己内酯)和磷脂基隐形纳米颗粒通过改善细胞内药物递送对小鼠乳腺癌具有增强的治疗效果。
Int J Nanomedicine. 2015 Mar 5;10:1791-804. doi: 10.2147/IJN.S75186. eCollection 2015.

引用本文的文献

1
Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers.癌症治疗的创新:内源性刺激响应脂质体作为先进的纳米载体
Pharmaceutics. 2025 Feb 13;17(2):245. doi: 10.3390/pharmaceutics17020245.
2
PEGylated Nanoliposomes Encapsulated with Anticancer Drugs for Breast and Prostate Cancer Therapy: An Update.用于乳腺癌和前列腺癌治疗的载抗癌药聚乙二醇化纳米脂质体:最新进展
Pharmaceutics. 2025 Feb 4;17(2):190. doi: 10.3390/pharmaceutics17020190.
3
Natural Food Components as Biocompatible Carriers: A Novel Approach to Glioblastoma Drug Delivery.

本文引用的文献

1
Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers.通过双重靶向纳米结构脂质载体增强硼替佐米的 BBB 和 BBTB 穿透性并改善抗脑胶质瘤作用。
J Control Release. 2022 May;345:371-384. doi: 10.1016/j.jconrel.2022.03.019. Epub 2022 Mar 15.
2
Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics.用于胶质母细胞瘤诊疗的多功能复合纳米材料的研究进展与展望
Pharmaceutics. 2022 Feb 21;14(2):456. doi: 10.3390/pharmaceutics14020456.
3
Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue.
天然食品成分作为生物相容性载体:胶质母细胞瘤药物递送的新方法
Foods. 2024 Sep 4;13(17):2812. doi: 10.3390/foods13172812.
4
Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation.PEG 化脂质体制剂介导的蜂毒靶向递送至 A549 肺癌细胞:凋亡研究。
Sci Rep. 2024 Jul 27;14(1):17302. doi: 10.1038/s41598-024-68156-6.
5
Enhancing the efficacy of letrozole-loaded PEGylated nanoliposomes against breast cancer cells: study.增强载有来曲唑的聚乙二醇化纳米脂质体对乳腺癌细胞的疗效:研究
Heliyon. 2024 Apr 30;10(9):e30503. doi: 10.1016/j.heliyon.2024.e30503. eCollection 2024 May 15.
6
Targeted Glioblastoma Treatment via Synthesis and Functionalization of Gold Nanoparticles With De Novo-Engineered Transferrin-Like Peptides: Protocol for a Novel Method.通过用从头设计的类转铁蛋白肽合成和功能化金纳米颗粒进行胶质母细胞瘤的靶向治疗:一种新方法的方案
JMIR Res Protoc. 2023 Aug 11;12:e49417. doi: 10.2196/49417.
7
PEGylated liposomes enhance the effect of cytotoxic drug: A review.聚乙二醇化脂质体增强细胞毒性药物的作用:综述。
Heliyon. 2023 Feb 17;9(3):e13823. doi: 10.1016/j.heliyon.2023.e13823. eCollection 2023 Mar.
基于脂质体的制剂:从基础研究到替莫唑胺在胶质母细胞瘤组织内递送的途径。
Pharmaceutics. 2022 Jan 27;14(2):308. doi: 10.3390/pharmaceutics14020308.
4
PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study.聚乙二醇化与非聚乙二醇化pH敏感脂质体:一项对比抗肿瘤活性研究的新见解
Pharmaceutics. 2022 Jan 24;14(2):272. doi: 10.3390/pharmaceutics14020272.
5
An Overview of Nanotechnologies for Drug Delivery to the Brain.用于脑部药物递送的纳米技术概述。
Pharmaceutics. 2022 Jan 19;14(2):224. doi: 10.3390/pharmaceutics14020224.
6
Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles.生物共轭纳米载体在(临床前)研究中穿越血脑屏障的最新进展,重点是囊泡。
J Control Release. 2022 Mar;343:777-797. doi: 10.1016/j.jconrel.2022.02.015. Epub 2022 Feb 17.
7
Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review.脂质体靶向治疗胶质瘤策略的最新进展:一项系统综述
ACS Appl Bio Mater. 2020 Sep 21;3(9):5500-5528. doi: 10.1021/acsabm.0c00705. Epub 2020 Sep 10.
8
Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy.三种合成转铁蛋白模拟短肽促进长春新碱脂质体透过血脑屏障用于提高脑胶质瘤靶向治疗。
Int J Pharm. 2022 Feb 5;613:121395. doi: 10.1016/j.ijpharm.2021.121395. Epub 2021 Dec 20.
9
To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.要不要聚乙二醇化:纳米医学最常用成分聚乙二醇及其替代品的免疫特性。
Adv Drug Deliv Rev. 2022 Jan;180:114079. doi: 10.1016/j.addr.2021.114079. Epub 2021 Dec 10.
10
Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.用于癌症诊疗的脂质纳米颗粒的最新进展:机遇与挑战
Pharmaceutics. 2021 Jun 7;13(6):840. doi: 10.3390/pharmaceutics13060840.